Blood Glucose Meter Row Must Be Arbitrated, Fla. Court Hears
Executives of a blood glucose meter manufacturer accused of "double-crossing" a Japanese medical products company in a $272.5 million deal with a Chinese biosensor company urged a Florida federal court on...To view the full article, register now.
Already a subscriber? Click here to view full article